Issue 6, 2013

Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation

Abstract

Formyl Peptide Receptors (FPRs) are vital in the host inflammatory response, playing an important regulatory role in multiple diseases. A Gd(III) DOTA conjugate of cFLFLFK has been synthesised which targets and visualises FPR1 upon leukocytes in the inflammatory response via magnetic resonance imaging for the first time.

Graphical abstract: Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation

Supplementary files

Article information

Article type
Communication
Submitted
12 Oct 2012
Accepted
26 Nov 2012
First published
27 Nov 2012

Chem. Commun., 2013,49, 564-566

Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation

G. J. Stasiuk, H. Smith, M. Wylezinska-Arridge, J. L. Tremoleda, W. Trigg, S. K. Luthra, V. M. Iveson, F. N. E. Gavins and N. J. Long, Chem. Commun., 2013, 49, 564 DOI: 10.1039/C2CC37460A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements